review·Nature reviews. Cancer·Nov 11, 2016BRONZE OA

Cancer nanomedicine: progress, challenges and opportunities

JSJinjun ShiPWPhilip W. KantoffRWRichard WoosterOCOmid C. FarokhzadCorresponding author

Brigham and Women's Hospital · Harvard University · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

5,582
total citations
FWCI
249.09
Percentile
100%
References
249
Citations per year

Authors

4
  • JS
    Jinjun Shi

    Brigham and Women's Hospital, Harvard University

  • PW
    Philip W. Kantoff

    Memorial Sloan Kettering Cancer Center

  • RW
    Richard Wooster
  • OC
    Omid C. FarokhzadCorresponding

    Brigham and Women's Hospital, King Abdulaziz University, Harvard University

Topics & keywords

Topics
  • Primary topicNanoparticle-Based Drug Delivery100%
  • Nanoplatforms for cancer theranostics100%
  • Graphene and Nanomaterials Applications100%
Keywords
  • Nanomedicine
  • Commercialization
  • Cancer
  • Cancer therapy
  • Nanotechnology
  • Cancer treatment
  • SAFER
  • Medicine
No related works found for this paper.

Funding

  • UD
    U.S. Department of Defense
    Awards: W81XWH, W81XWH-15-1
  • PC
    Prostate Cancer Foundation
  • MF
    Movember Foundation
  • NR
    National Research Foundation
  • NR
    National Research Foundation of Korea
    Award: K1A1A2048701
  • NI
    National Institutes of Health
    Awards: CA200900, CA151884, R00CA160350, W81XWH, EB015419
  • DP
    DOD Prostate Cancer Research Program